2014 - Transplant Infectious Disease Conference


Pesky Pathogens: Mycobacteria and Fungi

2.3 - Scedosporium

Presenter: Patricia, Munoz, Madrid, Spain
Authors: Patricia Munoz


Scedosporium spp. is a difficult to treat filamentous fungi that may cause very aggressive disease in transplantation recipients. It is ubiquitous and can be recovered from the environment (soil, polluted water, vegetation, etc). In some series S. apiospermum was responsible for 25% of invasive mycoses caused by filamentous fungi other than Aspergillus. Scedosporium may cause a wide spectrum of infections, but in the transplant population disseminated or deep-seated infections with a common skin, sinuses, lungs, and central nervous system involvement are especially worrying. Histopathological findings (septate, branching, hyaline hyphae) are similar to those of aspergillosis, so culture is usually necessary to confirm the identification. This species may be easily recovered from blood cultures. Voriconazole is the first line therapy for the susceptible species, but S. prolificans is uniformly resistant to all common antifungals. Surgery must be considered if feasible.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi